Patients with Alzheimer’s disease, compared to healthy people, are characterized by significantly higher levels of leptin, cystatin C and tau protein, and lower levels of neuropilin-1. This evidence concerns the gene NRP1 and early-onset autosomal dominant Alzheimer disease.